Prostate cancer: Clinical practice guidelines in oncology™

James Mohler, Robert R. Bahnson, Barry Boston, J. Erik Busby, Anthony D'Amico, James A. Eastham, Charles A. Enke, Daniel George, Eric Mark Horwitz, Robert P. Huben, Philip Kantoff, Mark Kawachi, Michael Kuettel, Paul H. Lange, Gary MacVicar, Elizabeth R. Plimack, Julio M. Pow-Sang, Mack Roach, Eric Rohren, Bruce J. RothDennis C. Shrieve, Matthew R. Smith, Sandy Srinivas, Przemyslaw Twardowski, Patrick C. Walsh

Research output: Contribution to journalReview article

512 Scopus citations

Abstract

The intention of these guidelines is to provide a framework on which to base treatment decisions. Prostate cancer is a complex disease, with many controversial aspects of management and a dearth of sound data to support treatment recommendations. Several variables (including life expectancy, disease characteristics, predicted outcomes, and patient preferences) must be considered by patients and physicians when tailoring prostate cancer therapy to the individual patient.

Original languageEnglish (US)
Pages (from-to)162-200
Number of pages39
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume8
Issue number2
DOIs
StatePublished - Feb 2010

Keywords

  • Active surveillance
  • Early detection
  • Life expectancy estimation
  • NCCN clinical practice guidelines
  • Prostate cancer
  • Prostate-specific antigen
  • Radiation therapy
  • Radical prostatectomy
  • Screening

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Prostate cancer: Clinical practice guidelines in oncology™'. Together they form a unique fingerprint.

  • Cite this

    Mohler, J., Bahnson, R. R., Boston, B., Busby, J. E., D'Amico, A., Eastham, J. A., Enke, C. A., George, D., Horwitz, E. M., Huben, R. P., Kantoff, P., Kawachi, M., Kuettel, M., Lange, P. H., MacVicar, G., Plimack, E. R., Pow-Sang, J. M., Roach, M., Rohren, E., ... Walsh, P. C. (2010). Prostate cancer: Clinical practice guidelines in oncology™. JNCCN Journal of the National Comprehensive Cancer Network, 8(2), 162-200. https://doi.org/10.6004/jnccn.2010.0012